|
⚲
|
| Hyperion Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001386858 |
| Sale | 2009-06-29 ($45.5 M Offered, $22.0 M Sold) |
| Fund | |
| Phone | 6457457802 |
| Address | 601 Gateway Blvd South San Francisco, 94080 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Nelligan Helena Regina
✚
|
0.0 | |
|
Nelsen Barbara
✚
|
0.0 | |
|
Faulkner Larry R
✚
|
0.0 | |
|
Nelson Diane
✚
|
0.0 | |
|
CAN Looma Series B-2 a Series of CGF2021 LLC
✚
|
0.0 | |
|
Cannabis Bioscience International Holdings, Inc.
✚
|
0.0 | |
|
Cannabis Suisse Corp
✚
|
0.0 | |
|
CANNA Corp
✚
|
0.0 | |
|
Cannada Charles T
✚
|
0.0 | |
|
Canino Vincent J.
✚
|
0.0 |